Literature DB >> 28306136

Detect to Prevent: Evaluating Testing and Treatment Practices for Latent Tuberculosis Infection in Long-Term Care Facilities.

Carla A Winston1, Nimalie D Stone2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28306136      PMCID： PMC5545749          DOI： 10.1111/jgs.14752

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  14 in total

1.  A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.

Authors:  Anne Marie France; Juliana Grant; J Steve Kammerer; Thomas R Navin
Journal:  Am J Epidemiol       Date:  2015-10-13       Impact factor: 4.897

2.  The Prevalence of Latent Tuberculosis Infection in the United States.

Authors:  James D Mancuso; Jeffrey M Diffenderfer; Bijan J Ghassemieh; David J Horne; Tzu-Cheg Kao
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

3.  Latent Tuberculosis Infection Testing Practices in Long-Term Care Facilities, Boston, Massachusetts.

Authors:  Divya Reddy; Jacob Walker; Laura F White; Gary H Brandeis; Matthew L Russell; Charles R Horsburgh; Natasha S Hochberg
Journal:  J Am Geriatr Soc       Date:  2017-05-03       Impact factor: 5.562

4.  Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2005-12-16

5.  Challenges in assessing transmission of Mycobacterium tuberculosis in long-term-care facilities.

Authors:  David A Jackson; Karen Mailer; Kimberly A Porter; R Todd Niemeier; Donna A Fearey; Linda Pope; Lauren A Lambert; Kiren Mitruka; Marie A de Perio
Journal:  Am J Infect Control       Date:  2015-05-05       Impact factor: 2.918

6.  Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.

Authors:  Dick Menzies; Richard Long; Anete Trajman; Marie-Josée Dion; Jae Yang; Hamdan Al Jahdali; Ziad Memish; Kamran Khan; Michael Gardam; Vernon Hoeppner; Andrea Benedetti; Kevin Schwartzman
Journal:  Ann Intern Med       Date:  2008-11-18       Impact factor: 25.391

7.  Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Authors:  E E Bliven-Sizemore; T R Sterling; N Shang; D Benator; K Schwartzman; R Reves; J Drobeniuc; N Bock; M E Villarino
Journal:  Int J Tuberc Lung Dis       Date:  2015-09       Impact factor: 2.373

8.  Recent Transmission of Tuberculosis - United States, 2011-2014.

Authors:  Courtney M Yuen; J Steve Kammerer; Kala Marks; Thomas R Navin; Anne Marie France
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

9.  Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Linda Bauman; Karina W Davidson; John W Epling; Francisco A R García; Jessica Herzstein; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; William R Phillips; Maureen G Phipps; Michael P Pignone
Journal:  JAMA       Date:  2016-09-06       Impact factor: 56.272

10.  Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Roque Miramontes; Andrew N Hill; Rachel S Yelk Woodruff; Lauren A Lambert; Thomas R Navin; Kenneth G Castro; Philip A LoBue
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240
View more
  1 in total

Review 1.  Review of Evidence for Using Chest X-Rays for Active Tuberculosis Screening in Long-Term Care in Canada.

Authors:  Mariana Herrera Diaz; Margaret Haworth-Brockman; Yoav Keynan
Journal:  Front Public Health       Date:  2020-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.